Abstract:Introduction Strategies for immunomodulation of xenograft rejection response whilst minimizing long-term immunosuppression need be developed. Polyclonal regulatory T cells (Treg) are suppressive of the xenoimmune responses. However, application of xenoantigen-specific Treg is required to achieve effective suppression and avoid opportunistic infection and malignancy for clinical xenotransplantation. We have previously shown that xenoantigen stimulation enhanced human Treg capacity to suppress the xenogeneic response. However, whether xenoantigen expanded Treg express specific cell surface markers which can be used for separating a particular xenoantigen-specific Treg subset for an effective Treg therapy needs be identified. In this study we investigated whether xenoantigen expanded human Treg express specific cell surface markers and their potential for selection of xenoantigen-specific Treg. Materials and Methods Human CD4+CD25+CD127- Treg isolated from healthy donor peripheral blood mononuclear cells (PBMC) were expanded for 3 or 4 cycles with anti-CD3/CD28 beads alone or combined with irradiated porcine PBMC as polyclonally (PlTreg) or xenoantigen stimulated Treg (XnTreg), respectively. Flow cytometry was performed to determine candidate cell surface markers and consequent xenoantigen-specific Treg subset was isolated XnTreg by cell sorting. After sorting, the resulting Treg subset was assessed for their suppressive capacity by mixed lymphocyte reaction (MLR) using irradiated porcine PBMC as xenogeneic stimulating cells, human PBMC as responder cells and autologous XnTreg as suppressing cells. Results After 3 and 4 cycles of expansion, although no difference was detected in expression of Treg activation markers CD39, CD45RO and CD15s on both XnTreg and PlTreg, XnTreg exhibited substantially upregulated expression of Treg memory markers HLA-DR and CD27 with a larger proportion of them being HLA-DR+CD27+. The HLA-DR+CD27+ Treg subset separated by cell sorting from XnTreg demonstrated significantly enhanced potency in suppression of proliferating xenoreactive responder cells at ratios of 1:4 through to 1:64, or 1:32 and 1:64 of Treg:responder cells when compared to HLA-DR+CD27+ cell-depleted or unsorted XnTreg, respectively. Discussion This study demonstrated that porcine xenoantigen expanded human Treg expressed elevated levels of Treg memory markers HLA-DR and CD27 which could be used for separation of xenoantigen-specific Treg subset. The effect of neutralizing HLA-DR and CD27 on HLA-DR+CD27+ Treg-mediated suppression of the xenogeneic response is being currently under investigation to facilitate their potential as specific markers for selection and enrichment of xenoantigen-specific human Treg. Conclusion Our data suggest that human HLA-DR+CD27+ memory-type Treg are xenoantigen-specific and have potential as an effective immunotherapy in xenotransplantation. Flow Cytometry Centre, WIMR. China Scholarship Council.

Human Hla-Dr+Cd27+Memory-Type Regulatory T Cells Show Potent Xenoantigen-Specific Suppression In Vitro

CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response

Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells

Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Porcine-Stimulated Human Tr1 Cells Showed Enhanced Suppression in Xenoantigen Stimulation Response

Ex Vivo Expansion of Human Tregs Specific for Alloantigens Presented Directly or Indirectly.

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice

Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

Efficient Induction and Expansion of Human Alloantigen-Specific Cd8 Regulatory T Cells from Naive Precursors by Cd40-Activated B Cells

Efficient Generation of Human Alloantigen-Specific CD4+ Regulatory T Cells from Naive Precursors by CD40-activated B Cells

Efficient Induction and Expansion of Human Alloantigen-Specific CD8 Regulatory T Cells from Naive Precursors by CD40-Activated B Cells1

T regulatory cells as an immunotherapy for transplantation.

T Regulatory Cells As an Immunotherapy for Transplantation

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

Human Regulatory T Cells Against Minor Histocompatibility Antigens: Ex Vivo Expansion for Prevention of Graft-Versus-host Disease.

IN VIVO ANTI-CD45RB ANTIBODY-INDUCED REGULATORY T CELLS DEMONSTRATE SPECIES-SPECIFIC TOLERANCE TO DISCORDANT HUMAN XENOGENIC ISLETS

Characterization of Protective Human CD4CD25 FOXP3 Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid.